# US 2026/0076885 A1 · Complexation of Oxybenzone with C-methylresorcin[4]arene

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076885 A1
- Document ID: US20260076885A1
- Status: Published application
- Kind: A1
- Application number: 19/402,209
- Filed: 2025-11-26
- Published: 2026-03-19
- Earliest claimed: 2021-06-11
- Assignees: University of Cincinnati
- Applicants: University of Cincinnati
- Inventors: Harshita Kumari; Xu Kang
- Web page: https://patentgrep.com/patent/US20260076885A1

## CPC

- A61K 8/35: Ketones, e.g. benzophenone
- A61K 8/347: {Phenols}
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61K 2800/58: Metal complex; Coordination compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention involves the formation of host-guest complexes between C-methylresorcin[4]arene and Oxybenzone (OXB). NMR spectroscopy confirmed the formation of a weak host-guest complex and molecular dynamics docking simulations indicated that this complex likely had a 1:1 stoichiometry. Furthermore, skin permeation testing revealed that complexation by C-methylresorcin[4]arene significantly reduced the amount of OXB that permeated skin. These results show the potential of supramolecular complexation for improving the stability and decreasing the skin permeability of OXB, thus limiting harmful side effects.

## Claims

### Claim 1

(canceled)

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7

A method of protecting a subject's skin from sun damage comprising applying a therapeutically effective amount of a composition comprising a cocrystal complex of oxybenzone with C-methylresorcin[4]arene (RsC1) to the skin of the subject.

### Claim 8

A method of protecting a subject's skin from sun damage comprising applying a therapeutically effective amount a sunscreen formulation comprising a cocrystal complex of oxybenzone with C-methylresorcin[4]arene (RsC1) to the skin of a subject in need of such treatment; wherein the cocrystal complex comprises from about 2 to about 10% by weight of the formulation.

### Claim 9 (depends on 8)

The method of claim 8 wherein the cocrystal complex comprises from about 4 to about 8% by weight of the formulation.

### Claim 10 (depends on 8)

The method of claim 8 wherein the sunscreen formulation further comprises a cosmetically acceptable carrier.

### Claim 11 (depends on 10)

The method of claim 10 wherein said carrier comprises one or more carriers selected from the group consisting of preservatives, emollients, emulsifying agents, surfactants, moisturizers, gelling agents, thickening agents, conditioning agents, film-forming agents, stabilizing agents, anti-oxidants, texturizing agents, gloss agents, mattifying agents, solubilizers, pigments, dyes, and fragrances.
